Global Shikimic Acid Market Strategic Research Report

Scope of the Report

The global Shikimic Acid market size is predicted to grow from US$ 43.35 million in 2025 to US$ 58.77 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032.

Shikimic Acid (CAS 138-59-0), is a cyclohexene, a cyclitol and a cyclohexanecarboxylic acid. It is an important biochemical metabolite in plants and microorganisms. It is a white fine powder, soluble in water, insoluble in chloroform, benzene and petroleum ether. Shikimic Acid (CAS 138-59-0) is mainly used as pharmaceutical intermediates, with a certain irritation.In 2025, global Shikimic Acid production reached approximately 411 MT.

Shikimic acid is a bio-based organic acid best known as a key intermediate in the manufacture of oseltamivir (Tamiflu) and related antiviral supply chains, and it also serves as a starting material for various fine chemicals. Market trends over the past decade have moved from heavy reliance on plant extraction (notably star anise and other botanical sources) toward more industrial bioprocess routes (fermentation and chemo-enzymatic processes). This shift has improved supply stability, reduced exposure to agricultural yield swings, and enabled tighter control of purity and cost—especially important for pharmaceutical-grade material.

On the demand side, the biggest driver remains pharmaceutical preparedness and influenza/respiratory disease cycles. Government stockpiling policies, public-health risk perception, and periodic surges in antiviral purchasing can cause “step changes” in demand, even when baseline consumption is steady. As more countries emphasize resilience in essential-medicine supply chains, buyers increasingly value reliable, scalable, qualified sources of shikimic acid (and validated downstream conversion capability), which supports long-term supplier agreements and capacity planning rather than purely spot-driven buying.

A second set of growth drivers comes from diversification beyond antivirals. Producers and downstream formulators continue exploring shikimic acid (and its derivatives) for specialty chemical synthesis, plus select cosmetic and personal-care positioning where “naturally derived” narratives and functional acid chemistries can be attractive (typically in niche volumes compared with pharma). In parallel, the broader push toward bio-based feedstocks is encouraging interest in shikimic acid as part of renewable chemical value chains—favoring manufacturers that can offer consistent quality grades (industrial vs. pharma), strong regulatory documentation, and cost-efficient fermentation scale-up.

This report presents a comprehensive overview of the global Shikimic Acid market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Shikimic Acid (98%)
• Shikimic Acid (99%)

Segment by Feature

• Solvent Extraction
• Resin Adsorption Method

Segment by Channel

• Direct Selling
• Distribution

Segment by Application

• Medicine and Veterinary Drugs
• Cosmetic and Personal Care
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Shikimic Acid market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medicine and Veterinary Drugs, Cosmetic and Personal Care, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact